ATE138808T1 - Antivirales material - Google Patents

Antivirales material

Info

Publication number
ATE138808T1
ATE138808T1 AT90915787T AT90915787T ATE138808T1 AT E138808 T1 ATE138808 T1 AT E138808T1 AT 90915787 T AT90915787 T AT 90915787T AT 90915787 T AT90915787 T AT 90915787T AT E138808 T1 ATE138808 T1 AT E138808T1
Authority
AT
Austria
Prior art keywords
pct
mannose
htlv
date
sec
Prior art date
Application number
AT90915787T
Other languages
English (en)
Inventor
Derek Stewart
John Marshall Scott Forrest
Werner E G Mueller
Original Assignee
Scottish Crop Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898924006A external-priority patent/GB8924006D0/en
Priority claimed from DE3940009A external-priority patent/DE3940009A1/de
Priority claimed from GB909006965A external-priority patent/GB9006965D0/en
Priority claimed from GB909011263A external-priority patent/GB9011263D0/en
Application filed by Scottish Crop Research Inst filed Critical Scottish Crop Research Inst
Application granted granted Critical
Publication of ATE138808T1 publication Critical patent/ATE138808T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/168—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4216—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig
    • C07K16/4225—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-viral Ig against anti-HIV Ig
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/974—Aids related test
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/827—Lectins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • AIDS & HIV (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
AT90915787T 1989-10-25 1990-10-25 Antivirales material ATE138808T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898924006A GB8924006D0 (en) 1989-10-25 1989-10-25 Anti-viral material
DE3940009A DE3940009A1 (de) 1989-12-02 1989-12-02 Mannose-spezifische lektine als diagnostikum und deren einsatz fuer diagnostische verfahren zum nachweis von onkogenen rna-viren oder bestandteilen von diesen
GB909006965A GB9006965D0 (en) 1990-03-28 1990-03-28 Anti-viral material
GB909011263A GB9011263D0 (en) 1990-05-19 1990-05-19 Anti-viral material

Publications (1)

Publication Number Publication Date
ATE138808T1 true ATE138808T1 (de) 1996-06-15

Family

ID=27434805

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90915787T ATE138808T1 (de) 1989-10-25 1990-10-25 Antivirales material

Country Status (10)

Country Link
US (1) US5462853A (de)
EP (1) EP0497825B1 (de)
JP (1) JPH05501877A (de)
AT (1) ATE138808T1 (de)
AU (1) AU6615090A (de)
CA (1) CA2071546A1 (de)
DE (1) DE69027330T2 (de)
OA (1) OA09657A (de)
RU (1) RU2082417C1 (de)
WO (1) WO1991006311A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0542833B1 (de) * 1990-07-30 1999-09-01 Novartis AG Insektizide proteine
GB9027185D0 (en) * 1990-12-14 1991-02-06 Rowett Research Inst Probiosis
JP2738908B2 (ja) * 1994-01-20 1998-04-08 保芦 将人 抗ウイルス粉末素材と抗ウイルスエキス
US6267993B1 (en) 1994-01-20 2001-07-31 Masahito Hoashi Plant-derived powder and an extract of the same
GB9406371D0 (en) * 1994-03-30 1994-05-25 Axis Genetics Ltd Nematicidal proteins
JPH08109134A (ja) * 1994-10-11 1996-04-30 Sanwa Kagaku Kenkyusho Co Ltd 細胞変成抑制並びに臓器毒性軽減剤
JPH1045601A (ja) * 1996-08-08 1998-02-17 Mitsuru Akashi 抗ウイルス素材
US6150123A (en) * 1998-09-03 2000-11-21 Centre Integre De Recherches Biocliniques Sur Le Sida (Cirbs) Affinity biotinylation
CN101124315A (zh) * 2003-01-17 2008-02-13 伊势龙医学股份有限公司 利用凝集素亲和性血液透析去除血液中病毒的方法
JP6818346B2 (ja) * 2016-04-28 2021-01-20 国立大学法人浜松医科大学 電子顕微鏡によるナノ粒子の直接的な同定・定量のための検出キットおよび方法
CN107955841B (zh) * 2017-12-15 2021-05-11 福建出入境检验检疫局检验检疫技术中心 同时检测七种水仙rna病毒的多重rt-pcr检测试剂盒及其检测方法
CN111118194B (zh) * 2020-01-07 2022-04-08 上海市农业科学院 石蒜属植物荧光est-ssr分子标记及其应用
US20220299512A1 (en) * 2020-04-06 2022-09-22 Medicortex Finland Oy Method for determining coronavirus and kit for the same
CN118027168B (zh) * 2024-03-19 2024-08-06 广东现代汉方科技有限公司 基于真核表达的msl重组植物蛋白的制备方法及用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61165334A (ja) * 1984-08-03 1986-07-26 メデイサ−チ、エス、ア− ウイルスの感染活性の抑制方法および組成物
JPH0825890B2 (ja) * 1987-06-18 1996-03-13 呉羽化学工業株式会社 抗ウイルス剤
DE3821686A1 (de) * 1988-06-28 1990-01-11 Werner E G Prof Dr Mueller Lektine als diagnostikum und deren einsatz fuer diagnostische verfahren zum nachweis von onkogenen rna-viren, oder deren bestandteile

Also Published As

Publication number Publication date
DE69027330T2 (de) 1997-02-06
JPH05501877A (ja) 1993-04-08
EP0497825A1 (de) 1992-08-12
WO1991006311A1 (en) 1991-05-16
AU6615090A (en) 1991-05-31
EP0497825B1 (de) 1996-06-05
CA2071546A1 (en) 1991-04-26
RU2082417C1 (ru) 1997-06-27
DE69027330D1 (de) 1996-07-11
OA09657A (en) 1993-05-15
US5462853A (en) 1995-10-31

Similar Documents

Publication Publication Date Title
DE69027330D1 (de) Antivirales material
CA2271622A1 (en) Antiviral agents from plant extracts and use for treatment of viral infections
WO1990015066A3 (fr) Sequences nucleotidiques issues du genome des retrovirus du type hiv-1, hiv-2 et siv, et leurs applications notamment pour l'amplification des genomes de ces retrovirus et pour le diagnostic in vitro des infections dues a ces virus
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
DE69323183D1 (de) Weitere indolderivate mit antiviraler wirkung
PT84155A (en) Method of modifying plant viruses or their effects
ATE164853T1 (de) Peptide, von virus-hiv-hüllen-glycoproteinen abstammend, deren verwendung zum nachweis einer infektion dieser viren und für die impfung gegen aids
DK0633887T3 (da) Antivirale calanolidforbindelser, præparater og anvendelser deraf
WO1990013281A3 (en) Method of suppressing hiv infection
ES2144400T3 (es) Gen que codifica la gliproteina d del virus del herpes equino de tipo 1, su producto genico, anticuerpos y su utilizacion.
DK720588D0 (da) Forbindelser til anvendelse ved behandling eller forebyggelse af human-immundefektvirus-(hiv)-infektion, og farmaceutiske praeparater indeholdende samme
DE69328102D1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
EP0316592A3 (de) 3'-Fluor-2',3'-dideoxyuridin und seine therapeutische Verwendung
FI881123L (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
Stewart et al. Detection of components of RNA viral glycoproteins using a mannose-specific lectin binding assay
DE69013134D1 (de) Extrakte von acanthospermum hispidum-pflanzen.
ES2080193T3 (es) Anticuerpos monoclonales contra la gp120 de vih.
IT1212737B (it) Derivati pirimidinici ad azione antivirale.
DK192990A (da) Laegemiddel til behandling eller forhindring, ved passiv immunisering, af hiv infektion og fremgangsmaader til fremstilling deraf
DE68929084D1 (de) Arzneimittel zur Verhinderung einer Infektion mit dem für AIDS verantwortlichen Virus
Desrosiers Will there be a live-attenuated HIV vaccine available for human safety trials by the year 2000? Interview by Gordon Nary
CA2401295A1 (en) Process for preparing an anti viral medicinal product from plant extracts
MY157594A (en) Compositions of matter useful in the treatment of viral infections derived from plant extracts
WO1998001144A2 (en) Antiviral agents from plant extracts and use for treatment of viral infections
FR2614025B1 (fr) Peptides susceptibles d'etre reconnus par des anticorps induits contre des retrovirus d'immunodeficience humaine (virus hiv) leurs applications au diagnostic des infections dues a certains de ces virus et, le cas echeant, a la vaccination contre le sida

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties